RespireRx Pharmaceuticals Inc. (RSPI)

RespireRx Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-1.94	-2.02	-3.87	-4.85	-2.52	-2.59
Depreciation & Amortization	390,911	390,911	552,787	374,080	215,575	8,378
Share-Based Compensation	0	0	0.06	0.38	0	0
Other Operating Activities	-390,908.97	-390,909.12	-552,784.15	-374,076.05	-215,572.97	-8,375.84
Operating Cash Flow	-0.25	-0.14	-0.96	-0.51	-0.49	-0.43
Common Stock Issued	0.17	0	0.12	0.16	0	0
Other Financing Activities	0.08	0.14	0.84	0.33	0.47	0.38
Financing Cash Flow	0.25	0.14	0.96	0.5	0.47	0.38
Net Cash Flow	0.01	-0	0	-0.02	-0.02	-0.05
Free Cash Flow	-0.25	-0.14	-0.96	-0.51	-0.49	-0.43
Free Cash Flow Per Share	-0.00	-0.00	-0.01	-0.02	-1.25	-1.28

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.